lamisil 1 %w/w cutaneous spray solution
novartis pharmaceuticals uk ltd - terbinafine hydrochloride - cutaneous spray solution - 1 %w/w - antifungals for systemic use
lamisil at 1 %w/w cutaneous spray solution
novartis consumer health uk limited - terbinafine hydrochloride - cutaneous spray solution - 1 %w/w
lamisil at 1% spray
haleon uk ltd - terbinafine hydrochloride - spray - 10mg/1gram
lamisil at
novartis consumer health uk limited - terbinafine hydrochloride - cutaneous spray solution - 1 %w/w
lamisil spray
novartis pharmaceuticals canada inc - terbinafine hydrochloride - spray - 1% - terbinafine hydrochloride 1% - allylamines
lamisil terbinafine 250mg (as hydrochloride) tablet
novartis pharmaceuticals australia pty ltd - terbinafine hydrochloride, quantity: 281.25 mg (equivalent: terbinafine, qty 250 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose; colloidal anhydrous silica - treatment in adults of ringworm (tinea corporis, tinea cruris and tinea pedis) due to infection caused by dermatophytes such as trichophyton (eg. t.rubrum, t.mentagrophytes, t.verrucosum, t.violaceum), microsporum canis and epidermophyton floccosum, where oral therapy is considered appropriate owing to the site, severity or extent of the infection, and the infection is not responsive to topical therapy. onychomycosis in adults (fungal infection of the nail) caused by dermatophyte fungi.
lamisil tablet 250 mg
novartis (singapore) pte ltd - terbinafine hcl eqv terbinafine - tablet, film coated - 250 mg - terbinafine hcl eqv terbinafine 250 mg
lamisil once
gsk consumer healthcare, israel ltd - terbinafine as hydrochloride - solution - terbinafine as hydrochloride 10 mg/g - other antifungals for topical use - for the treatment of athlete's foot.